Invion Ltd.ASX: IVX

Activities Report and Appendix 4C

· Issued by Invion Ltd.

Filed with ASX · · 9 pages · English

Summary by 6ix AI

The report highlights progress in a skin cancer trial and promising results from a prostate cancer trial, alongside updates on industry partnerships. Financially, Invion reported cash reserves at the end of the quarter and outlined its cash inflows and outflows, including payments to related parties. The company aims to leverage trial data for further cancer research and has appointed a new Scientific Advisor to guide its clinical programs.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Invion Ltd. on 6ix

Story so far

Earlier from Invion

Later from Invion

All Invion news releases